Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,960 | 0,989 | 13:02 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.06. | Nanoform Finland Oyj: Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide | 637 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | June 12, 2025 at 08:10:00 EEST
HELSINKI, FINLAND, June 12, 2025 - Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had... ► Artikel lesen | |
20.05. | Nanoform Finland Oyj: Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS technology | 819 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | May 20, 2025 at 08:10:00 EEST
Term sheets agreed for several key markets around nanoenzalutamide1). First term sheet also signed around nanoencorafenib2). Negotiations... ► Artikel lesen | |
15.04. | Nanoform Finland Oyj: Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | 643 | GlobeNewswire (Europe) | Company release
Nanoform Finland Plc
April 15, 2025
14.10 Finnish time / 13.10 Swedish time
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Nanoform Finland... ► Artikel lesen | |
15.04. | Resolutions of Nanoform Finland Plc's Annual General Meeting on April 15, 2025 | 2 | Cision News | ||
NANOFORM FINLAND Aktie jetzt für 0€ handeln | |||||
17.03. | Notice to the Annual General Meeting of NANOFORM FINLAND Plc | 4 | Cision News | ||
27.02. | Nanoform Finland Oyj: Nanoform 2024 report: Deal discussions around product kernels intensify | 1.151 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
February 27, 2025
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform 2024 report: Deal discussions around product kernels intensify
After a strong... ► Artikel lesen | |
13.02. | Invitation to Nanoform's Q4 and FY 2024 Report Presentation | 2 | Cision News | ||
18.11.24 | Nanoform Finland Oyj: Nanoform Q3 2024 report: Record number of new projects signed | 1.048 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
November 18, 2024
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform Q3 2024 report: Record number of new projects signed
A record number of new... ► Artikel lesen | |
15.08.24 | NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT | 1.314 | PR Newswire | HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 25,800 | +2,18 % | Formycon-Aktie gewinnt 2,76 Prozent (26,10 €) | Die Formycon-Aktie notiert heute ein wenig fester. Das Wertpapier kostete zuletzt 26,10 Euro. Ein Wertanstieg von 2,76 Prozent steht gegenwärtig für die Formycon-Aktie zu Buche. Das Papier verteuerte... ► Artikel lesen | |
ONTO INNOVATION | 89,50 | +1,13 % | What Analysts Are Saying About Onto Innovation Stock | ||
SOLESENCE | 3,350 | +8,06 % | Solésence, Inc.: Solésence Reports Second Quarter 2025 Financial Results | ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced... ► Artikel lesen | |
GOMSPACE | 1,000 | 0,00 % | GomSpace Group AB: GomSpace reports positive net profit in Q1 2025 | GomSpace releases its Q1 2025 trading statement and reports a strong revenue growth, positive operational EBITDA and a positive net profit in the first quarter.
FIRST QUARTER OF 2025
Order intake... ► Artikel lesen | |
LAMPETIA | 0,116 | -3,33 % | EQS-News: LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Jahresergebnis
LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis
30.06.2025 / 16:18 CET/CEST
Für den... ► Artikel lesen | |
GAUZY | 6,260 | 0,00 % | Alejandro Weinstein rejoins Gauzy's board as company streamlines leadership | ||
KOPIN | 1,668 | +0,85 % | KOPIN CORP - 8-K, Current Report | ||
DOTZ NANO | 0,022 | -4,44 % | DOTZ NANO LIMITED: Application for quotation of securities - DTZ | ||
VEECO INSTRUMENTS | 19,800 | -2,94 % | Veeco's Q2 revenue, operating income and EPS exceed guidance, but constrained by tariffs | ||
NVE | 52,50 | -1,87 % | Dividendenbekanntmachungen (04.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIPRISE FINANCIAL INC US03076C1062 1,6 USD 1,3806 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0258 EUR ATLANTIC UNION... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,035 | +7,93 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company using... ► Artikel lesen | |
NANOFOCUS | 1,120 | 0,00 % | NanoFocus: Hauptaktionär plant Squeeze-out | Die Carl Mahr Holding GmbH hat ein offizielles Verlangen auf Durchführung eines aktienrechtlichen Squeeze-outs bei der NanoFocus AG übermittelt. Demnach soll die Hauptversammlung einen Beschluss fassen... ► Artikel lesen | |
OBDUCAT | 0,024 | +9,09 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
ACACIA RESEARCH | 2,700 | 0,00 % | Acacia Research und Partner entwickeln eine mit Bitcoin gesicherte Gewerbedarlehensstrategie | ||
ADVANCE ZINCTEK | 0,575 | +0,88 % | ADVANCE ZINCTEK LIMITED: Response to ASX Price Query |